TopicMOG Diseases

In recent years, several paediatric monophasic and multiphasic immune-mediated acquired demyelinating syndromes (ADS) like acute disseminated encephalomyelitis, optic neuritis and transverse myelitis have been shown to be associated with the presence of antibodies targeting myelin oligodendrocyte glycoprotein (MOG-ab), a small yet important component of the myelin sheet. Importantely, this entity here called MOG- associated diseases (MOGAD), is clearly distinct from other diseases such as childhood MS or AQP4 associated NMOSD.
This webinar will therefore primarily address clinical relevant aspects of this y new disease entity such as role of MOG abs in the disease process, which technique to use for MOG-abs testing, spectrum of monophasic/multiphasic diseases associated with MOG antibodies, how to treat children with MOGAD in addition remaining open questions.

Speaker: Professor Kevin Rostasy, EPNS Board Member, Head of Paediatric Neurology, Witten/Herdecke University, Children’s Hospital Datteln.

Date: Wednesday 9 December 2020

Time: 17:00h Central European Time

To find out more: CLICK HERE

To register: CLICK HERE


If you aren’t already a member, why not consider joining the European Paediatric Neurology Society (EPNS)?

Membership is open to all paediatric neurologists and colleagues in related fields. By becoming a member you will join a rapidly growing group of like-minded active professionals in your field who are committed to improving standards of care of all children with suspected neurological problems and to collaborating on training, continuing medical education and research.


EPNS New Member Application form: CLICK HERE